{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:37Z","timestamp":1772165797117,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary vascular disease (PVD) and pulmonary hypertension (PH) is a significant disorder affecting prognosis of extremely preterm infants. However, there is still a lack of a consensus on the definition and optimal treatments of PH, and there is also a lack of research comparing these conditions with persistent pulmonary hypertension of newborn (PPHN), early PH, and late PH. To investigate PH in extremely preterm infants, this study compared the baseline characteristics, short-term outcomes, and treatment duration, categorized by the timing of requiring PH treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study retrospectively analyzed extremely preterm infants admitted to a single tertiary center. Between 2018 and 2022, infants with clinical or echocardiographic diagnosis of PH who required treatment were divided into three groups based on the timing of treatment initiation: initial 3\u00a0days (extremely early-period), from day 4 to day 27 (early-period), and after day 28 (late-period). The study compared the outcomes, including mortality rates, bronchopulmonary dysplasia (BPD) severity, PH treatment duration, and oxygen therapy duration, among the three groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the 157 infants, 67 (42.7%) were treated for PH during their stay. Of these, 39 (57.3%) were treatment in extremely early, 21 (31.3%) in early, and seven (11.4%) in late periods. No significant differences were observed in maternal factors, neonatal factors, or morbidity between the three groups. However, infants who received extremely early-period treatment had a higher mortality rate, but shorter duration of noninvasive respiratory support, oxygen therapy, and PH medication use. On the other hand, the late-period treatment group received longer durations of respiratory support and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed differences in mortality rates, respiratory outcomes, and treatment duration between the three groups, suggesting varying pathophysiologies over time in extremely preterm infants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-024-04943-4","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T06:01:47Z","timestamp":1721455307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants"],"prefix":"10.1186","volume":"24","author":[{"given":"Ki Teak","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Han","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ee-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"issue":"1","key":"4943_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.4103\/2045-8932.109954","volume":"3","author":"T Peng","year":"2013","unstructured":"Peng T, Morrisey EE. Development of the pulmonary vasculature: current understanding and concepts for the future. Pulm Circ. 2013;3(1):176\u20138.","journal-title":"Pulm Circ."},{"issue":"9815","key":"4943_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(11)61621-8","volume":"379","author":"RM Berger","year":"2012","unstructured":"Berger RM, Beghetti M, Humpl T, Raskob GE, Ivy DD, Jing ZC, Bonnet D, Schulze-Neick I, Barst RJ. Clinical features of paediatric pulmonary hypertension: a registry study. Lancet. 2012;379(9815):537\u201346.","journal-title":"Lancet"},{"issue":"4","key":"4943_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1017\/S1047951116000871","volume":"27","author":"H Ishida","year":"2017","unstructured":"Ishida H, Kawazu Y, Kayatani F, Inamura N. Prognostic factors of premature closure of the ductus arteriosus in utero: a systematic literature review. Cardiol Young. 2017;27(4):634\u20138.","journal-title":"Cardiol Young"},{"issue":"7","key":"4943_CR4","doi-asserted-by":"publisher","first-page":"e00080","DOI":"10.1161\/HHF.0000000000000080","volume":"16","author":"P-N Jone","year":"2023","unstructured":"Jone P-N, Ivy DD, Hauck A, Karamlou T, Truong U, Coleman RD, Sandoval JP, Mar\u00edn MJdC, Eghtesady P, Tillman K, Krishnan US. Pulmonary hypertension in congenital heart disease: a scientific statement from the American Heart Association. Circ Heart Fail. 2023;16(7):e00080.","journal-title":"Circ Heart Fail."},{"issue":"6","key":"4943_CR5","doi-asserted-by":"publisher","first-page":"F554","DOI":"10.1136\/archdischild-2017-313778","volume":"103","author":"H Nakanishi","year":"2018","unstructured":"Nakanishi H, Suenaga H, Uchiyama A, Kusuda S. Neonatal research network J: persistent pulmonary hypertension of the newborn in extremely preterm infants: a Japanese cohort study. Arch Dis Child Fetal Neonatal Ed. 2018;103(6):F554\u201361.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"4943_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.clp.2015.08.010","volume":"42","author":"PM Mourani","year":"2015","unstructured":"Mourani PM, Abman SH. Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia. Clin Perinatol. 2015;42(4):839\u201355.","journal-title":"Clin Perinatol"},{"key":"4943_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-pathol-012513-104644","volume":"10","author":"JA Whitsett","year":"2015","unstructured":"Whitsett JA, Wert SE, Weaver TE. Diseases of pulmonary surfactant homeostasis. Annu Rev Pathol. 2015;10:371\u201393.","journal-title":"Annu Rev Pathol"},{"key":"4943_CR8","doi-asserted-by":"crossref","unstructured":"Mirza H, Mandell EW, Kinsella JP, McNamara PJ, Abman SH. Pulmonary vascular phenotypes of prematurity: the path to precision medicine. J Pediatr. 2023;259:113444.","DOI":"10.1016\/j.jpeds.2023.113444"},{"issue":"3","key":"4943_CR9","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4070\/kcj.2010.40.3.131","volume":"40","author":"HS An","year":"2010","unstructured":"An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, Kim HS, Choi JH, Noh CI, Yun YS. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J. 2010;40(3):131\u20136.","journal-title":"Korean Circ J"},{"issue":"5","key":"4943_CR10","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jpeds.2014.07.040","volume":"165","author":"H Mirza","year":"2014","unstructured":"Mirza H, Ziegler J, Ford S, Padbury J, Tucker R, Laptook A. Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia. J Pediatr. 2014;165(5):909-914 e901.","journal-title":"J Pediatr."},{"key":"4943_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpeds.2022.07.039","volume":"251","author":"S Arjaans","year":"2022","unstructured":"Arjaans S, Fries MWF, Schoots MH, Schilte CFM, Roofthooft MTR, Vrijlandt E, Bos AF, Kooi EMW, Berger RMF. Clinical Significance of Early Pulmonary Hypertension in Preterm Infants. J Pediatr. 2022;251:74\u201381.","journal-title":"J Pediatr"},{"issue":"1","key":"4943_CR12","doi-asserted-by":"publisher","first-page":"11206","DOI":"10.1038\/s41598-021-90769-4","volume":"11","author":"HH Kim","year":"2021","unstructured":"Kim HH, Sung SI, Yang MS, Han YS, Kim HS, Ahn SY, Jeon GW, Chang YS, Park WS. Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants. Sci Rep. 2021;11(1):11206.","journal-title":"Sci Rep"},{"issue":"1","key":"4943_CR13","doi-asserted-by":"publisher","first-page":"14186","DOI":"10.1038\/s41598-022-18345-y","volume":"12","author":"YJ Kim","year":"2022","unstructured":"Kim YJ, Shin SH, Park HW, Kim EK, Kim HS. Risk factors of early pulmonary hypertension and its clinical outcomes in preterm infants: a systematic review and meta-analysis. Sci Rep. 2022;12(1):14186.","journal-title":"Sci Rep"},{"issue":"8","key":"4943_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1164\/rccm.201803-0428OC","volume":"199","author":"PM Mourani","year":"2019","unstructured":"Mourani PM, Mandell EW, Meier M, Younoszai A, Brinton JT, Wagner BD, Arjaans S, Poindexter BB, Abman SH. Early pulmonary vascular disease in preterm infants is associated with late respiratory outcomes in childhood. Am J Respir Crit Care Med. 2019;199(8):1020\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4943_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","volume":"191","author":"PM Mourani","year":"2015","unstructured":"Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;191(1):87\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"4943_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223\u201330.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4943_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-197801000-00001","volume":"187","author":"MJ Bell","year":"1978","unstructured":"Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, Brotherton T. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1\u20137.","journal-title":"Ann Surg."},{"key":"4943_CR18","doi-asserted-by":"crossref","unstructured":"Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, Mah ML, Bhombal S, Smith CV, McNamara PJ, et al. Patent ductus arteriosus: a contemporary perspective for the pediatric and adult cardiac care provider. J Am Heart Assoc. 2022;11(17):e025784.","DOI":"10.1161\/JAHA.122.025784"},{"issue":"6","key":"4943_CR19","first-page":"751","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan AF, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am\u00a0J\u00a0Respir\u00a0Crit\u00a0Care Med. 2019;200(6):751\u20139.","journal-title":"Am\u00a0J\u00a0Respir\u00a0Crit\u00a0Care Med."},{"issue":"3","key":"4943_CR20","doi-asserted-by":"publisher","first-page":"L508","DOI":"10.1152\/ajplung.00135.2002","volume":"284","author":"TR Grover","year":"2003","unstructured":"Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2003;284(3):L508-517.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"4943_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1164\/rccm.201707-1371OC","volume":"197","author":"B Wallace","year":"2018","unstructured":"Wallace B, Peisl A, Seedorf G, Nowlin T, Kim C, Bosco J, Kenniston J, Keefe D, Abman SH. Anti-sFlt-1 therapy preserves lung alveolar and vascular growth in antenatal models of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2018;197(6):776\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4943_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1164\/rccm.202003-0601OC","volume":"202","author":"K Hirsch","year":"2020","unstructured":"Hirsch K, Taglauer E, Seedorf G, Callahan C, Mandell E, White CW, Kourembanas S, Abman SH. Perinatal hypoxia-inducible factor stabilization preserves lung alveolar and vascular growth in experimental bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2020;202(8):1146\u201358.","journal-title":"Am J Respir Crit Care Med"},{"key":"4943_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jpeds.2018.02.034","volume":"198","author":"H Mirza","year":"2018","unstructured":"Mirza H, Garcia JA, Crawford E, Pepe J, Zussman M, Wadhawan R, Oh W. Natural history of postnatal cardiopulmonary adaptation in infants born extremely preterm and risk for death or bronchopulmonary dysplasia. J Pediatr. 2018;198:187\u201393.","journal-title":"J Pediatr"},{"issue":"3","key":"4943_CR24","doi-asserted-by":"publisher","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","volume":"283","author":"TD Le Cras","year":"2002","unstructured":"Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol. 2002;283(3):L555-562.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"4943_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.semperi.2013.01.002","volume":"37","author":"BW Buczynski","year":"2013","unstructured":"Buczynski BW, Maduekwe ET, O\u2019Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol. 2013;37(2):69\u201378.","journal-title":"Semin Perinatol"},{"issue":"1","key":"4943_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000358374","volume":"106","author":"DH Kim","year":"2014","unstructured":"Kim DH, Kim HS. Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension. Neonatology. 2014;106(1):55\u201361.","journal-title":"Neonatology"},{"issue":"1","key":"4943_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000327891","volume":"101","author":"DH Kim","year":"2012","unstructured":"Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH. Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology. 2012;101(1):40\u20136.","journal-title":"Neonatology"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04943-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04943-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T06:03:26Z","timestamp":1721455406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04943-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4943"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04943-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4241546\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of Seoul National University Hospital (IRB No.: 2310-128-1478; approval date: November 06, 2023), and the requirement for informed consent was waived by the Institutional Review Boarder of Seoul National University Hospital owing to the retrospective nature of the study. The study was conducted in accordance with the principles stated in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}